CEO Ozawa Spoke at 'RINK FESTIVAL 2025'
On February 14, 2025, Epistra CEO Yosuke Ozawa spoke at “RINK FESTIVAL 2025,” hosted by Kanagawa Prefecture. The event was organized by RINK (Regenerative medicine & Cell therapy industrialization network of Kanagawa) and held at TIAT SKY HALL in Haneda Airport Terminal 3.
Ozawa organized Session B “The Future of Regenerative Medicine Opened by AI” starting at 15:00, presenting on the transformative potential of AI technology in the regenerative medicine field and our company’s initiatives. Specifically, he introduced cutting-edge technologies and their applications toward practical implementation of regenerative medicine, including culture condition optimization using AI, automation of culture processes through integration with robotics, and improvements in data analysis and quality control.
The following experts also presented in the session, leading to active discussions:
- Mr. Takashi Suzuki, Group Leader, Cell Analysis Group, Cell Business Unit, Shimadzu Corporation
- Mr. Hideto Yamaguchi, Director, Drug Substance Research Laboratories, CMC Development; Director, Tsukuba Bio Research Center, Astellas Pharma Inc.
- Dr. Koichi Takahashi, Team Leader, BioSystems Dynamics Research Center, RIKEN
- Prof. Ryuji Kato, Associate Professor, Graduate School of Pharmaceutical Sciences, Nagoya University
Kanagawa Regenerative & Cell Therapy Industrialization Network RINK https://rink.kanagawa.jp/
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.